Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Suitors Take Note as Bay Area's Nektar May Be Up for Sale February 4, 2018 Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene July 5, 2017 Caris Life Sciences' Molecular Intelligence Platform Identifies Patients With MSI-High (Or Mismatch Repair Deficient) Solid Tumors More Likely To Respond To Immunotherapy June 8, 2017
Caris Life Sciences' Molecular Intelligence Platform Identifies Patients With MSI-High (Or Mismatch Repair Deficient) Solid Tumors More Likely To Respond To Immunotherapy June 8, 2017
